Peer-influenced content. Sources you trust. No registration required. This is HCN.
British Medical Journal
The question of whether, when, and how children and adolescents with gender dysphoria should be treated medically or surgically is contentious. Gender dysphoria in the United States is being treated with “gender affirming care,” which may include gonadotrophin releasing hormone analogues (GnRHa) to suppress puberty, oestrogen or testosterone to promote secondary sex characteristics, and surgical removal or augmentation of breasts, genitals, or other physical features. At the same time, several European countries have issued guidelines limiting medical intervention in minors and emphasizing psychological care. There is little doubt in the medical community that children in distress require care, but there are concerns about the rapid widespread adoption of interventions and calls for rigorous scientific review from all corners.
Endocrinology, Diabetes, Metabolism March 7th 2023
Medical Professionals Reference (MPR)
Sunlenca (lenacapavir), which comes in 300 mg tablets and a 463.5 mg/1.5 mL injection, provides doctors with a long-needed twice-yearly option for patients with complicated past treatment histories who would otherwise have few treatment options.
Allergy & Immunology January 11th 2023
The American Journal of Psychiatry
The American Journal of Psychiatry presents this review of the most compelling articles that were covered in 2022: The Molecular and Cellular Alterations That Underpin Psychiatric Illnesses Shared and Distinct Neurobiological Mechanisms of PTSD Cognitive Deficits in Long-Term Cannabis Users Longitudinal Outcomes of Duration of Untreated Psychosis Accelerating TMS in the Treatment of Depression Infant Brain Development, Fragile X Syndrome, and Autism Spectrum Disorder Combining Computational Modeling and Postmortem Human Brain Studies to Uncover Synaptic Variability Contributions to Cortical Gamma Oscillation From the AJP Residents’ Journal: Identity and Stigma
Psychiatry January 10th 2023
TheBodyPro
A trio of posters look at clinical effectiveness fostemsavir for multidrug-resistant patients, real-world efficacy of the dolutegravir/lamivudine combination as a switch strategy, and a newer drug in the pipeline, islatravir prodrug BRII-732.
Infectious Diseases December 7th 2022
Journal of Clinical Oncology
An update of Simone’s Maxims that include the lived experiences of medical professionals who identify as women, under-represented groups in medicine (UrIM), or who have several underrepresented identities and who face many hurdles in academic medicine is necessary in light of the realities of contemporary medicine.
Oncology, Medical October 3rd 2022
MedPage Today
An efficacy number that’s been widely and unquestioningly quoted by various media organizations — “85% effective” or “at least 85% effective” — is based entirely on a small study done in Africa in the 1980s that has major limitations and with “pretty weak” findings.
Family Medicine/General Practice August 10th 2022